CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 77 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-08-01 | Harel Adrian Chief Executive Officer | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2012-08-01 | Harel Adrian Chief Executive Officer | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2011-08-10 | Harel Adrian Acting Chief Executive Officer | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2011-06-27 | Harel Adrian Acting Chief Executive Officer | Grant or award · Stock Option (right to buy) | +450,000 | 450,000 |
Page 1 of 1 · 4 trades